FDA authorizes second emergency use Ebola test
![fda-ebola](/sites/default/files/styles/900x400/public/2018-11/fda-ebola.jpg?itok=uwQReNSm)
The Food and Drug Administration has issued an emergency use authorization for a rapid, single-use test to detect Ebola virus. The test is the second Ebola fingerstick test to receive an EUA, but the first to use a portable battery-operated reader. “By authorizing the first fingerstick test with a portable reader, we hope to better arm health care providers in the field to more quickly detect the virus in patients and improve patient outcomes,” said FDA Commissioner Scott Gottlieb, M.D., noting that the agency continues to collaborate with federal, international and industry partners to assist in the global response to the Ebola outbreak in the Democratic Republic of Congo.
Related News Articles
Headline
As a precaution in response to the recent Ebola outbreak in Uganda, the Centers for Disease Control and Prevention and Department of Homeland Security Customs…
Headline
The Centers for Disease Control and Prevention today issued an advisory to remind U.S. clinicians of best practices for evaluating patients for suspected Ebola…
Headline
The Centers for Disease Control and Prevention today joined the global public health community in marking the end of the Ebola outbreak in the Democratic…
Headline
With Ebola outbreaks in the Democratic Republic of the Congo and Guinea, the Centers for Disease Control and Prevention is reminding U.S. health care personnel…
Headline
Health officials in Guinea Sunday declared an Ebola outbreak in the nation’s southeastern N’Zerekore prefecture after confirming three cases in the rural…
Headline
The Centers for Disease Control and Prevention today joined the global public health community in marking the end of the Ebola outbreak in the Democratic…